黑料网

Purpose: To evaluate the safety and efficacy of IW-3718 in patients with Gastroesophageal Reflux Disease (GERD)
Principal Investigator: Nicholas Shaheen, MD MPH
Sponsor: Ironwood Pharmaceuticals, Inc.

Visit clinicaltrials.gov to learn more about this

Currently enrolling by invitation only

Purpose: To evaluate the efficacy (eosinophil count) of AK002 in patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE)
Principal Investigator: Evan Dellon, MD MPH
Sponsor: Allakos, Inc.

Visit clinicaltrials.gov to learn more about this

A Phase 2, Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients with Eosinophilic Gastritis with or without Eosinophilic Gastroenteritis (AK002-003)

Enrollment Closed
Purpose: To evaluate the efficacy (histological response) of AK002 in adults with Eosinophilic Gastritis (EG) with ir without Eosinophilic Gastroenteritis (EGE)
Principal Investigator: Evan Dellon, MD MPH
Sponsor: Allakos

Visit clinicaltrials.gov to learn more about the

聽A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Investigation of the EndoStim庐 Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Gastroesophageal Reflux Disease (GERD), Protocol # CS-100

Enrollment Closed
Purpose: To demonstrate the safety and effectiveness of the EndoStim庐 Lower Esophageal Sphincter (LES) Stimulation System in the treatment of subjects with gastroesophageal reflux disease (GERD)
Principal Investigator: Dr. Nicholas J. Shaheen, MD, MPH
Sponsor: EndoStim

Visit clinicaltrials.gov to learn more about the